Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Stohr

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Histopathology|August 5, 2025
Classification of prostatic adenocarcinoma as favourable/unfavourable histology has high interobserver agreement in prostate needle core biopsiesChien-Kuang C Ding, Huijun Xiao, Jane K Nguyen, et al.
The American Journal of Surgical Pathology|December 19, 2019
"Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct EntityRajal B Shah, Bradley A Stohr, Zheng Jin Tu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 4, 2016
Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneitySu-Yang Liu, Nancy M Joseph, Ajay Ravindranathan, et al.
Nature|August 1, 2014
Replication stress is a potent driver of functional decline in ageing haematopoietic stem cellsJohanna Flach, Sietske T Bakker, Mary Mohrin, et al.
Nature Communications|January 11, 2022
Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell statesHanbing Song, Hannah N W Weinstein, Paul Allegakoen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2021
Heterogeneity in <i>NECTIN4</i> Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab VedotinCarissa E Chu, Martin Sjöström, Emily A Egusa, et al.
European Urology Oncology|July 20, 2023
Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer SubtypesMeera R Chappidi, Martin Sjöström, Nancy Y Greenland, et al.
Nature Communications|June 17, 2025
Bladder cancer variants share aggressive features including a CA125+ cell state and targetable TM4SF1 expressionHeiko Yang, Hanbing Song, Elizabeth Yip, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 17, 2018
Polyoma virus-associated carcinomas of the urologic tract: a clinicopathologic and molecular studyDeepika Sirohi, Charlie Vaske, Zack Sanborn, et al.
European Urology Oncology|February 26, 2022
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant CellsJonathan Chou, Kai Trepka, Martin Sjöström, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Histopathology|August 5, 2025
Classification of prostatic adenocarcinoma as favourable/unfavourable histology has high interobserver agreement in prostate needle core biopsiesChien-Kuang C Ding, Huijun Xiao, Jane K Nguyen, et al.
The American Journal of Surgical Pathology|December 19, 2019
"Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct EntityRajal B Shah, Bradley A Stohr, Zheng Jin Tu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 4, 2016
Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneitySu-Yang Liu, Nancy M Joseph, Ajay Ravindranathan, et al.
Nature|August 1, 2014
Replication stress is a potent driver of functional decline in ageing haematopoietic stem cellsJohanna Flach, Sietske T Bakker, Mary Mohrin, et al.
Nature Communications|January 11, 2022
Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell statesHanbing Song, Hannah N W Weinstein, Paul Allegakoen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2021
Heterogeneity in <i>NECTIN4</i> Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab VedotinCarissa E Chu, Martin Sjöström, Emily A Egusa, et al.
European Urology Oncology|July 20, 2023
Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer SubtypesMeera R Chappidi, Martin Sjöström, Nancy Y Greenland, et al.
Nature Communications|June 17, 2025
Bladder cancer variants share aggressive features including a CA125+ cell state and targetable TM4SF1 expressionHeiko Yang, Hanbing Song, Elizabeth Yip, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 17, 2018
Polyoma virus-associated carcinomas of the urologic tract: a clinicopathologic and molecular studyDeepika Sirohi, Charlie Vaske, Zack Sanborn, et al.
European Urology Oncology|February 26, 2022
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant CellsJonathan Chou, Kai Trepka, Martin Sjöström, et al.
Pageof 7